Physicians

Department / Division
Medicine / Medicine - Oncology

Address
DUMC 3505
Durham, NC 27710

10 Bryan Searle Drive, Room 432
Durham, NC 27710

Appointment Telephone
919-668-6688

Fax Telephone
919-613-5228

Training

• MD, Medical College of Ohio (University of Toledo College of Medicine), 2002

Residency

• Internal Medicine, University of Cincinnati Medical Center (Ohio), 2002-2005

Fellowship

• Hematology/Medical Oncology, Duke University Medical Center, 2005-2008

Other Training

• MHS, Clinical Research, Duke University, 2009

Clinical Interests
Gastrointestinal oncology, including pancreatic, esophageal, gastric, and colorectal cancers; research interests in health services, access to colorectal cancer care, and supportive care

Industry Relationships and Collaborations (What's this?)

This physician (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.

• Amgen, Inc.
• Genentech, Inc (Roche Holding)

Representative Publications
Altomare I, Bendell JC, Bullock KE, Uronis HE, Morse MA, Hsu SD, Zafar SY, Blobe GC, Pang H, Honeycutt W, Sutton L, Hurwitz HI. A phase II trial of bevacizumab plus everolimus for patients with refractory metastatic colorectal cancer. Oncologist. 2011;16(8):1131-7. (2011) Abstract

Bullock KE, Petros WP, Younis I, Uronis HE, Morse MA, Blobe GC, Zafar SY, Gockerman JP, Lager JJ, Truax R, Meadows KL, Howard LA, O'Neill MM, Broadwater G, Hurwitz HI, Bendell JC. A phase I study of bevacizumab (B) in combination with everolimus (E) and erlotinib (E) in advanced cancer (BEE). Cancer Chemother Pharmacol. 2011 Feb;67(2):465-74. (2011) Abstract

Currow DC, Foley K, Zafar SY, Wheeler JL, Abernethy AP. The need for a re-evaluation of best supportive care studies reported to date. Br J Cancer. 2011 Feb 1;104(3):390-1. (2011) Abstract

Hirsch BR, Zafar SY. Capecitabine in the management of colorectal cancer. Cancer Manag Res. 2011;3:79-89. (2011) Abstract

Palta M, Patel P, Broadwater G, Willett C, Pepek J, Tyler D, Zafar SY, Uronis H, Hurwitz H, White R, Czito B. Carcinoma of the Ampulla of Vater: Patterns of Failure Following Resection and Benefit of Chemoradiotherapy. Ann Surg Oncol. 2011 Nov 2. (2011) Abstract

Phelan SM, Griffin JM, Jackson GL, Zafar SY, Hellerstedt W, Stahre M, Nelson D, Zullig LL, Burgess DJ, van Ryn M. Stigma, perceived blame, self-blame, and depressive symptoms in men with colorectal cancer. Psychooncology. 2011 Sep 26. (2011) Abstract

Zafar SY, Malin JL, Grambow SC, Abbott DH, Schrag D, Kolimaga JT, Zullig LL, Weeks JC, Fouad MN, Ayanian JZ, Wallace R, Kahn KL, Ganz PA, Catalano P, West DW, Provenzale D, . Early dissemination of bevacizumab for advanced colorectal cancer: a prospective cohort study. BMC Cancer. 2011;11:354. (2011) Abstract

Abernethy AP, Ahmad A, Zafar SY, Wheeler JL, Reese JB, Lyerly HK. Electronic patient-reported data capture as a foundation of rapid learning cancer care. Med Care. 2010 Jun;48(6 Suppl):S32-8. (2010) Abstract

Abernethy AP, Aziz NM, Basch E, Bull J, Cleeland CS, Currow DC, Fairclough D, Hanson L, Hauser J, Ko D, Lloyd L, Morrison RS, Otis-Green S, Pantilat S, Portenoy RK, Ritchie C, Rocker G, Wheeler JL, Zafar SY, Kutner JS. A strategy to advance the evidence base in palliative medicine: formation of a palliative care research cooperative group. J Palliat Med. 2010 Dec;13(12):1407-13. (2010) Abstract

Abernethy AP, Wheeler JL, Zafar SY. Management of gastrointestinal symptoms in advanced cancer patients: the rapid learning cancer clinic model. Curr Opin Support Palliat Care. 2010 Mar;4(1):36-45. (2010) Abstract

Abernethy AP, Zafar SY, Uronis H, Wheeler JL, Coan A, Rowe K, Shelby RA, Fowler R, Herndon JE 2nd. Validation of the Patient Care Monitor (Version 2.0): a review of system assessment instrument for cancer patients. J Pain Symptom Manage. 2010 Oct;40(4):545-58. (2010) Abstract

Bull J, Zafar SY, Wheeler JL, Harker M, Gblokpor A, Hanson L, Hulihan D, Nugent R, Morris J, Abernethy AP. Establishing a regional, multisite database for quality improvement and service planning in community-based palliative care and hospice. J Palliat Med. 2010 Aug;13(8):1013-20. (2010) Abstract

Chrischilles EA, Pendergast JF, Kahn KL, Wallace RB, Moga DC, Harrington DP, Kiefe CI, Weeks JC, West DW, Zafar SY, Fletcher RH. Adverse events among the elderly receiving chemotherapy for advanced non-small-cell lung cancer. J Clin Oncol. 2010 Feb 1;28(4):620-7. (2010) Abstract

Jackson GL, Melton LD, Abbott DH, Zullig LL, Ordin DL, Grambow SC, Hamilton NS, Zafar SY, Gellad ZF, Kelley MJ, Provenzale D. Quality of nonmetastatic colorectal cancer care in the Department of Veterans Affairs. J Clin Oncol. 2010 Jul 1;28(19):3176-81. (2010) Abstract

Zafar SY, Currow DC, Daugherty CK, Abernethy AP. Standards for palliative care delivery in oncology settings. Cancer J. 2010 Sep-Oct;16(5):436-43. (2010) Abstract

Zafar SY, Marcello JE, Wheeler JL, Rowe KL, Morse MA, Herndon JE 2nd, Abernethy AP. Treatment-related toxicity and supportive care in metastatic colorectal cancer. J Support Oncol. 2010 Jan-Feb;8(1):15-20. (2010) Abstract

Abernethy AP, Barbour SY, Uronis H, Zafar SY, Coan A, Rowe K, Pupa MR, Wheeler JL, Herndon JE 2nd. Quality management of potential chemotherapy-induced neutropenic complications: evaluation of practice in an academic medical center. Support Care Cancer. 2009 Jun;17(6):735-44. (2009) Abstract

Abernethy AP, Wheeler JL, Zafar SY. Detailing of gastrointestinal symptoms in cancer patients with advanced disease: new methodologies, new insights, and a proposed approach. Curr Opin Support Palliat Care. 2009 Mar;3(1):41-9. (2009) Abstract

Cherny NI, Abernethy AP, Strasser F, Sapir R, Currow D, Zafar SY. Improving the methodologic and ethical validity of best supportive care studies in oncology: lessons from a systematic review. J Clin Oncol. 2009 Nov 10;27(32):5476-86. (2009) Abstract

Dupont A, Wheeler J, Herndon JE 2nd, Coan A, Zafar SY, Hood L, Patwardhan M, Shaw HS, Lyerly HK, Abernethy AP. Use of tablet personal computers for sensitive patient-reported information. J Support Oncol. 2009 May-Jun;7(3):91-7. (2009) Abstract

Zafar SY, Alexander SC, Weinfurt KP, Schulman KA, Abernethy AP. Decision making and quality of life in the treatment of cancer: a review. Support Care Cancer. 2009 Feb;17(2):117-27. (2009) Abstract

Zafar SY, Marcello JE, Wheeler JL, Rowe KL, Morse MA, Herndon JE, Abernethy AP. Longitudinal patterns of chemotherapy use in metastatic colorectal cancer. J Oncol Pract. 2009 Sep;5(5):228-33. (2009) Abstract

Zafar SY, Abernethy AP, Abbott DH, Grambow SC, Marcello JE, Herndon JE 2nd, Rowe KL, Kolimaga JT, Zullig LL, Patwardhan MB, Provenzale DT. Comorbidity, age, race and stage at diagnosis in colorectal cancer: a retrospective, parallel analysis of two health systems. BMC Cancer. 2008;8:345. (2008) Abstract

Zafar SY, Currow D, Abernethy AP. Defining best supportive care. J Clin Oncol. 2008 Nov 1;26(31):5139-40. (2008) Abstract

Zafar SY, Howell DN, Gockerman JP. Malignancy after solid organ transplantation: an overview. Oncologist. 2008 Jul;13(7):769-78. (2008) Abstract